APA (7th ed.) Citation

B, R., S, K., P, P., A, M., S, N. P., S, J., . . . VGM, N. (2026). IITZ01 attenuates fructose aggravated ulcerative colitis via prevention of macrophage activation and decrease in cytokine release via inhibition of PIP5 kinase. International immunopharmacology, 182, 116808. https://doi.org/10.1016/j.intimp.2026.116808

Chicago Style (17th ed.) Citation

B, Rajdev, Kundu S, Panja P, Mandal A, N P. S, Jain S, Gangasani JK, and Naidu VGM. "IITZ01 Attenuates Fructose Aggravated Ulcerative Colitis via Prevention of Macrophage Activation and Decrease in Cytokine Release via Inhibition of PIP5 Kinase." International Immunopharmacology 182 (2026): 116808. https://doi.org/10.1016/j.intimp.2026.116808.

MLA (9th ed.) Citation

B, Rajdev, et al. "IITZ01 Attenuates Fructose Aggravated Ulcerative Colitis via Prevention of Macrophage Activation and Decrease in Cytokine Release via Inhibition of PIP5 Kinase." International Immunopharmacology, vol. 182, 2026, p. 116808, https://doi.org/10.1016/j.intimp.2026.116808.